213 related articles for article (PubMed ID: 21996938)
21. Deep brain stimulation in the central nucleus of the amygdala decreases 'wanting' and 'liking' of food rewards.
Ross SE; Lehmann Levin E; Itoga CA; Schoen CB; Selmane R; Aldridge JW
Eur J Neurosci; 2016 Oct; 44(7):2431-2445. PubMed ID: 27422085
[TBL] [Abstract][Full Text] [Related]
22. Intermittent bilateral deep brain stimulation of the nucleus accumbens shell reduces intravenous methamphetamine intake and seeking in Wistar rats.
Batra V; Tran TL; Caputo J; Guerin GF; Goeders NE; Wilden J
J Neurosurg; 2017 Apr; 126(4):1339-1350. PubMed ID: 27392268
[TBL] [Abstract][Full Text] [Related]
23. Deep brain stimulation alters light phase food intake microstructure in rats.
Prinz P; Kobelt P; Scharner S; Goebel-Stengel M; Harnack D; Faust K; Winter Y; Rose M; Stengel A
J Physiol Pharmacol; 2017 Jun; 68(3):345-354. PubMed ID: 28820391
[TBL] [Abstract][Full Text] [Related]
24. Deep brain stimulation of the nucleus accumbens shell induces anti-obesity effects in obese rats with alteration of dopamine neurotransmission.
Zhang C; Wei NL; Wang Y; Wang X; Zhang JG; Zhang K
Neurosci Lett; 2015 Mar; 589():1-6. PubMed ID: 25578952
[TBL] [Abstract][Full Text] [Related]
25. Body fat and body weight reduction following hypothalamic deep brain stimulation in monkeys: an intraventricular approach.
Torres N; Chabardes S; Piallat B; Devergnas A; Benabid AL
Int J Obes (Lond); 2012 Dec; 36(12):1537-44. PubMed ID: 22349575
[TBL] [Abstract][Full Text] [Related]
26. Deep brain stimulation and obesity.
Mavridis I; Anagnostopoulou S
J Neurosurg; 2013 Feb; 118(2):485-7. PubMed ID: 23240703
[No Abstract] [Full Text] [Related]
27. A systematic review on neuromodulation therapies for reducing body weight in patients with obesity.
Gouveia FV; Silk E; Davidson B; Pople CB; Abrahao A; Hamilton J; Ibrahim GM; Müller DJ; Giacobbe P; Lipsman N; Hamani C
Obes Rev; 2021 Oct; 22(10):e13309. PubMed ID: 34337843
[TBL] [Abstract][Full Text] [Related]
28. Prefronto-cerebellar neuromodulation affects appetite in obesity.
Marron EM; Viejo-Sobera R; Cuatrecasas G; Redolar-Ripoll D; Lorda PG; Datta A; Bikson M; Magerowski G; Alonso-Alonso M
Int J Obes (Lond); 2019 Oct; 43(10):2119-2124. PubMed ID: 30538282
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Safety and Outcome of Lateral Hypothalamic Deep Brain Stimulation for Obesity in a Small Series of Patients With Prader-Willi Syndrome.
Franco RR; Fonoff ET; Alvarenga PG; Alho EJL; Lopes AC; Hoexter MQ; Batistuzzo MC; Paiva RR; Taub A; Shavitt RG; Miguel EC; Teixeira MJ; Damiani D; Hamani C
JAMA Netw Open; 2018 Nov; 1(7):e185275. PubMed ID: 30646396
[TBL] [Abstract][Full Text] [Related]
30. An Open-Label Clinical Trial of Hypothalamic Deep Brain Stimulation for Human Morbid Obesity: BLESS Study Protocol.
De Salles AAF; Barbosa DAN; Fernandes F; Abucham J; Nazato DM; Oliveira JD; Cury A; Biasi A; Rossi R; Lasagno C; Bueno PT; Santos RHN; Damiani LP; Gorgulho AA
Neurosurgery; 2018 Oct; 83(4):800-809. PubMed ID: 29538761
[TBL] [Abstract][Full Text] [Related]
31. Long-term results after deep brain stimulation of nucleus accumbens and the anterior limb of the internal capsule for preventing heroin relapse: An open-label pilot study.
Chen L; Li N; Ge S; Lozano AM; Lee DJ; Yang C; Li L; Bai Q; Lu H; Wang J; Wang X; Li J; Jing J; Su M; Wei L; Wang X; Gao G
Brain Stimul; 2019; 12(1):175-183. PubMed ID: 30245163
[TBL] [Abstract][Full Text] [Related]
32. Rationale for hypothalamus-deep brain stimulation in food intake disorders and obesity.
Torres N; Chabardès S; Benabid AL
Adv Tech Stand Neurosurg; 2011; 36():17-30. PubMed ID: 21197606
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic approach to obesity based on the regulatory mechanism of feeding behavior and energy metabolism].
Yoshimatsu H
Nihon Rinsho; 2006 Dec; 64 Suppl 9():668-78. PubMed ID: 17458300
[No Abstract] [Full Text] [Related]
34. Brain stimulation in obesity.
Göbel CH; Tronnier VM; Münte TF
Int J Obes (Lond); 2017 Dec; 41(12):1721-1727. PubMed ID: 28663570
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of deep brain stimulation of the nucleus accumbens in morbid obesity.
Oterdoom DLM; van Dijk G; Verhagen MHP; Jiawan VCR; Drost G; Emous M; van Beek AP; van Dijk JMC
Neurosurg Focus; 2018 Aug; 45(2):E10. PubMed ID: 30064329
[TBL] [Abstract][Full Text] [Related]
36. Food intake behaviour in man: implications for treatment of obesity.
Hashim SA; Porikos K
Clin Endocrinol Metab; 1976 Jul; 5(2):503-16. PubMed ID: 782748
[No Abstract] [Full Text] [Related]
37. The role of corticostriatal-hypothalamic neural circuits in feeding behaviour: implications for obesity.
Clarke RE; Verdejo-Garcia A; Andrews ZB
J Neurochem; 2018 Dec; 147(6):715-729. PubMed ID: 29704424
[TBL] [Abstract][Full Text] [Related]
38. Hypothalamic regulation of food intake and clinical therapeutic applications.
Simpson KA; Martin NM; Bloom SR
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):120-8. PubMed ID: 19466203
[TBL] [Abstract][Full Text] [Related]
39. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications.
Hoebel BG; Hernandez L; Schwartz DH; Mark GP; Hunter GA
Ann N Y Acad Sci; 1989; 575():171-91; discussion 192-3. PubMed ID: 2699187
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial.
Oliveria SF; Rodriguez RL; Bowers D; Kantor D; Hilliard JD; Monari EH; Scott BM; Okun MS; Foote KD
Lancet Neurol; 2017 Sep; 16(9):691-700. PubMed ID: 28642125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
